DoD Tuberous Sclerosis Complex, Idea Development Award
ID: 353645Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353645
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Tuberous Sclerosis Complex (TSC) Idea Development Award, a federal grant aimed at supporting innovative research that addresses high-impact findings in TSC. This opportunity encourages applications that propose conceptually innovative research with a strong scientific rationale and preliminary data, focusing on areas such as neuropsychiatric disorders, tumor prevention, and epilepsy treatments associated with TSC. With an estimated total program funding of $2.4 million and the expectation of awarding three grants, the application process includes a pre-application due by June 12, 2024, followed by a full application due by August 1, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524TSCRPIDA_GG.pdf
    The Department of Defense's FY24 Tuberous Sclerosis Complex Research Program seeks applications for the Idea Development Award aimed at high-impact research relevant to Service Members, Veterans, and the public. The application process involves a two-step submission, starting with a pre-application due by June 12, 2024, followed by a full application due by August 1, 2024. This funding opportunity, with $8 million appropriated for FY24, emphasizes research that innovatively addresses areas like neuropsychiatric disorders associated with Tuberous Sclerosis Complex (TSC), tumor prevention, and epilepsy treatments. Eligible applicants include independent investigators, both established and those new to TSC research, with a budget cap of $500,000 for a maximum performance period of three years. The review process is two-tiered, involving peer and programmatic assessments, with a focus on impact, innovation, and feasibility of the proposed studies. The announcement outlines strict submission guidelines and eligibility criteria to ensure compliance with funding regulations while promoting advancements in TSC research.
    Similar Opportunities
    Tuberculosis Research Units (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the establishment of multidisciplinary Tuberculosis Research Units (TBRUs) through a grant program aimed at enhancing the understanding of Mycobacterium tuberculosis (Mtb) and its interactions with the host. This initiative seeks to foster collaborative research that characterizes the roles of bacterial and host heterogeneity in infection outcomes and disease progression, with a focus on identifying determinants relevant to Mtb establishment and dissemination. The total estimated program funding is $10 million, with approximately five awards expected, and interested applicants are encouraged to begin forming collaborations in anticipation of the Notice of Funding Opportunity (NOFO) expected to be published in September 2025. For further inquiries, potential applicants can contact Richard T. Robinson, Ph.D., at richard.robinson@nih.gov or by phone at 202-607-8565.
    NFRP Outreach and Invitation for Response
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is forecasting an opportunity for a Research-based Other Transactions Agreement (rOTA) under the Neurofibromatosis Research Program (NFRP). This initiative aims to accelerate the clinical translation of basic research related to neurofibromatosis (NF) by conducting collaborative Phase I and II clinical trials focused on promising therapeutic agents for NF1, NF2, and schwannomatosis. Historically, this requirement has been addressed through assistance agreements, and the government is now seeking feedback on this proposed approach, emphasizing the need for cost-sharing arrangements and access to patient populations. Interested parties can direct inquiries to Jason D. Kuhns at jason.d.kuhns.civ@mail.mil, with the opportunity being part of the FY21 portfolio and requiring a demonstrated history of collaborative research among participants.
    INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the INCLUDE Project: Transformative Research Awards for Down syndrome, aimed at advancing innovative research to improve health and quality of life for individuals with Down syndrome. This funding opportunity invites applications for groundbreaking research that can establish new scientific paradigms or develop transformative technologies related to Down syndrome and its co-occurring conditions, with no preliminary data required. The program has an estimated total funding of $3 million, with individual awards ranging from $250,000 to $500,000, and is expected to support approximately four projects. Interested applicants can reach out to Dr. Charlene Schramm at schrammc@nih.gov or by phone at 301-402-3793, with applications due by February 19, 2026, and anticipated awards announced by September 1, 2026.
    Staff Research Program
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity for the Staff Research Program, aimed at engaging scientific staff in collaborative research with higher education institutions. This program seeks to enhance the professional competence of Army Research Office (ARO) scientists through hands-on, fundamental research in various scientific fields, including engineering, physical sciences, and life sciences, with a focus on advancing knowledge relevant to Army missions. Eligible applicants include institutions recognized for their scientific research capabilities, and the funding will be provided through cooperative agreements with award amounts ranging from $200,000 to $10 million. Proposals must be submitted via Grants.gov by June 2, 2030, and interested parties can contact Mr. William Creech at William.a.creech3.civ@army.mil for further information.
    INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome, aimed at enhancing health and quality of life for individuals with Down syndrome. This funding opportunity invites researchers to propose innovative exploratory and developmental projects that address critical needs identified in the INCLUDE Project objectives, potentially leading to breakthroughs in biomedical, behavioral, or clinical research. The total estimated program funding is $1 million, with individual awards ranging from $50,000 to $200,000, and the application process is open to a diverse range of eligible applicants, including tribal governments and community-based organizations. Interested parties should contact Dr. Melissa Parisi at 301-728-1861 or via email at parisima@mail.nih.gov for further information, with applications due by February 19, 2026, and awards expected to be announced by September 1, 2026.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Molecular and Neural Mechanisms of Non-Invasive Brain Stimulation to Treat Substance Use Disorders
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Molecular and Neural Mechanisms of Non-Invasive Brain Stimulation to Treat Substance Use Disorders," aimed at encouraging basic research on Non-Invasive Brain Stimulation (NIBS) techniques such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). The objective is to elucidate the molecular, cellular, and circuit-level changes induced by NIBS protocols and to identify the mechanisms by which these techniques produce therapeutic effects in treating substance use disorders. This research is crucial as it seeks to optimize treatment parameters for addiction therapies, with an estimated total program funding of $3 million and an expected four awards to be made. Interested applicants, particularly small businesses with expertise in neuromodulation and addiction, should prepare for the application process, with the estimated synopsis post date set for March 5, 2026, and the estimated award date on April 1, 2027. For further inquiries, contact Subramaniam Ananthan, Ph.D., at sam.ananthan@nih.gov or call 301-435-2199.
    National Child Traumatic Stress Initiative - Treatment and Service Adaptation
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled the National Child Traumatic Stress Initiative - Treatment and Service Adaptation. This initiative aims to provide national expertise in addressing specific types of traumatic events and population groups, facilitating the adaptation of effective evidence-based treatment and service approaches for communities across the United States. The program is critical for enhancing mental health services for children affected by trauma, with an estimated total funding of $14,400,000 available for approximately 24 awards in fiscal year 2026. Interested applicants, which include domestic public and private nonprofit entities, can reach out to Jennifer Isely at jennifer.isely@samhsa.hhs.gov or (240) 276-2563 for further information, with the synopsis expected to be posted on February 27, 2026.
    National Child Traumatic Stress Initiative - Community Treatment and Service Centers
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled the National Child Traumatic Stress Initiative - Community Treatment and Service Centers. This initiative aims to enhance access to effective trauma-focused treatment and services for children, adolescents, and their families who have experienced traumatic events. The program is critical in addressing the mental health needs of affected youth, ensuring they receive the necessary support to recover and thrive. The estimated total program funding is $40,200,000, with approximately 67 awards expected to be made. Interested applicants, which include domestic public and private nonprofit entities, can reach out to Elisabeth McCall Martin at (240) 276-2252 or via email at elisabeth.mccallmartin@samhsa.hhs.gov for further information. The opportunity is currently posted, with the last update on December 10, 2025, and the synopsis is expected to be available by February 27, 2026.